ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2024 Results Conference Call February 26, 2025 4:30 PM ET Company Participants Al Kildani - SVP of Investor Relations & Corporate Communications Catherine Owen Adams - CEO Tom Garner - COO Elizabeth Thompson - EVP, Head of R&D Mark Schneyer - EVP, CFO Conference Call Participants Ami Fadia - Needham & Company Tessa Romero - JPMorgan Joel Beatty - Baird Tazeen Ahmad - Bank of America Securities Gregory Renza - RBC Capital Markets Charles Duncan - Cantor Sumant Kul ...

Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call February 26, 2025 04:30 PM ET Company Participants Andrew McKibben - Vice President of Investor Relations and FinanceChris Peetz - President and Chief Executive OfficerJoanne Quan - Chief Medical OfficerEric Bjerkholt - Chief Financial OfficerGavin Clark-Gartner - Director - Biotechnology Equity ResearchRyan Mcelroy - Equity Research AssociateRyan Deschner - Vice President - Equity ResearchJon Wolleben - Managing Director Conference Call Participants Je ...

CANbridge Pharmaceuticals (01228) Update / Briefing June 07, 2023 12:00 PM ET Speaker0 Good day, ladies and gentlemen. Welcome to Cambridge's Live Marley Mainland China approval call. It's our great honor to have the following management with us here today. Doctor James Hsu, founder, chairman, and CEO of Cambridge Pharmaceuticals. Doctor. Gerald Cox, Chief Development Strategist Marcelo Tureski, Chief Commercial Officer and Glenn Hassan, Chief Financial Officer. Management team will give us a presentation o ...